Orthofix Medical Inc.

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 17/07/2024 BST			5-day change	1st Jan Change
16.2 ^USD	+0.37%		+8.51%	+20.18%

07-16	Orthofix Names Stephanie Walsh as Chief Human Resources Officer	CI
07-09	Orthofix Medical Gets 510(k) Clearance for Fitbone System	MT

Orthofix Medical Seeks Acquisitions

January 11, 2018 at 05:00 am

Orthofix Medical Inc. (NasdaqGS:OFIX) will pursue substantial value-accretive acquisitions.

Latest news about Orthofix Medical Inc.

Orthofix Names Stephanie Walsh as Chief Human Resources Officer	07-16	CI
Orthofix Medical Gets 510(k) Clearance for Fitbone System	07-09	MT
Orthofix Medical Inc. Announces First Implant of Fitbone Transport and Lengthening System	07-09	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Defensive Index	06-30	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Value-Defensive Index	06-30	CI
Orthofix Medical Names Michael Finegan as Board Chair	06-24	MT
Orthofix Medical Inc. Appoints Michael Finegan as Chair of Board of Directors	06-24	CI
Kimberley A. Elting Departs as President, Global Orthopedics of Orthofix Medical Inc	06-20	CI
Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality	06-18	CI
Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer	06-11	CI
Orthofix Medical Inc. Appoints Max Reinhardt as President of Global Spine Business Effective June 10, 2024	05-23	CI
Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	05-09	CI
Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target	05-08	MT
Transcript : Orthofix Medical Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M	05-07	MT
Orthofix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024	05-07	CI
Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	04-16	CI
Orthofix Medical Inc. Announces Board Resignation	04-12	CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer	03-18	CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set	03-05	MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024	03-05	CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024	03-05
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M	03-05	MT

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

05/08/2024 - Q2 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Orthofix Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.2 USD

Average target price

20.13 USD

Spread / Average Target

+24.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORTHOFIX MEDICAL INC.	+20.18%	606M
ABBOTT LABORATORIES	-4.90%	179B
MEDTRONIC PLC	-1.36%	100B
DEXCOM, INC.	-7.64%	46.16B
HOYA CORPORATION	+13.65%	44.81B
CENCORA, INC.	+9.63%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.63%	29.53B
TERUMO CORPORATION	+20.42%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-7.12%	23.97B
STERIS PLC	+4.03%	22.5B

Other Medical Equipment, Supplies & Distribution

Orthofix Medical Inc.

Equities

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Orthofix Medical Seeks Acquisitions

Latest news about Orthofix Medical Inc.

Chart Orthofix Medical Inc.

Company Profile

Income Statement Evolution

Ratings for Orthofix Medical Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution